Clinical trials
Completed Phase 1 trials in Lithuania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Imcyse SA | 2 |
| Amgen | 1 |
| Bayer | 1 |
| Berlin-Chemie AG Menarini Group | 1 |
| CorFlow Therapeutics AG | 1 |
| Incyte Corporation | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Molecular Partners AG | 1 |
| National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 2 |
| Autoimmune Diseases | 1 |
| Hematologic Diseases | 1 |
| Hodgkin Disease | 1 |
| Hyperparathyroidism, Secondary | 1 |
| Leukemia | 1 |
| Low Anterior Resection Syndrome | 1 |
| Lymphoma | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.